tirzepatide alcohol use disorder Semaglutide and Tirzepatide reduce alcohol
Description
Your provider may recommend a slower titration schedule
One study found that around 4% of people taking 5 mg of Zepbound discontinued the medication due to side effects, whereas 7.1% of people taking the 10 mg dose and 6.2% of people taking the 15 mg dose discontinued the medication
India Regulatory Landscape The CDSCO has approved Mounjaro KwikPen for type 2 diabetes in strengths from 2.5 to 15 mg
Recent evidence suggests that gastrointestinal side effects are usually temporary and resolve with time, while the risk for pancreatitis, gallbladder disease and hypoglycaemia appears comparable to GLP1 receptor agonists
Diabetes Obes Metab 2021;23:529
